Tags: impact investingfinancial returnsmeasurable impactMultiple myeloma,plasma cell cancer,bone marrow cancer,M protein,CRAB symptoms,monoclonal gammopathy,stem cell transplant,immunomodulatory drugs,proteasome inhibitors,skeletal survey,serum free light chain assay,bone lesions,hypercalcemia,renal insufficiency,anemiaacademia, community , CRISPR, editorial, impact factor